PATIENT SUPPORT
The TYVASO DPI 90-Day Trial Program allows you to assess the tolerability and efficacy of TYVASO DPI with your patients
- The program is offered to eligible patients at no cost for up to 90 days
- Your patients have no obligation to continue taking TYVASO DPI at the end of the trial period
- Eligibility for this program is limited to patients with PAH (WHO Group 1) or PH-ILD (WHO Group 3). This program is not valid for: patients currently using TYVASO DPI, Orenitram® (treprostinil) Extended-Release Tablets, TYVASO® (treprostinil) Inhalation Solution, or Remodulin® (treprostinil) Injection; patients who previously used TYVASO DPI outside of the hospital setting; patients currently on an inhaled, oral, or infused prostacyclin. For other eligibility criteria, see full Terms and Conditions on the Enrollment Form
United Therapeutics Cares™: United for your patients
United Therapeutics Cares is a patient support program that connects your patients with a dedicated team of specialists who provide education on access, affordability, and treatment support from day one. Our team will work one-on-one with your patients to provide ongoing, personalized support including:
- Education & Expectations: keeping patients informed about their treatment and what’s next in their United Therapeutics treatment journey
- Coverage & Reimbursement: initiating the benefits investigation process and setting expectations on prior authorizations, appeals, and reimbursement needs
- Cost & Savings: education on United Therapeutics co-pay assistance and patient assistance programs
- Prescription Coordination: oversight throughout the referral process, working directly with one of our specialty pharmacy partners to triage your prescription, confirm coverage, and monitor prescription status
- Treatment Support: regular patient check-ins and access to Patient Education Specialists who can be an additional resource during your patient’s United Therapeutics treatment journey
Visit
UnitedTherapeuticsCares.com
to learn more and enroll your patient today.
Call United Therapeutics Cares at 1-844-864-8437, Monday through Friday, 8:30 am - 7 pm ET.
United Therapeutics Cares Co-Pay Assistance Program*
With the United Therapeutics Cares Co-Pay Assistance Program, most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.
For full program details and Terms and Conditions, visit www.UTcopay.com.
*To enroll in this Program, your patients must understand and agree to comply with the eligibility requirements and terms of use.
Eligibility requirements for this Program are:
- Patients must be 18 years or older to use this Program.
- Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible.
- The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication. The Program is only valid for the cost of the treprostinil product and not applicable to any related supplies or other medical expenses associated with administering the product.
- Eligible patients must be residents of the US or Puerto Rico. The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program.
DPI=dry powder inhaler; PAH=pulmonary arterial hypertension; WHO=World Health Organization.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.